EORTC-24851-HNCG

PHASE II STUDY OF 4'-EPIDoxorubicin IN RECURRENT OR METASTATIC ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK.
Trial StatusAll trial activities ended
DatesDate of activation: 15-Jan-86
Closed on : 15-Feb-89
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size14
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
@
Back to Protocol section